Cyberonics, Inc. (NASDAQ:CYBX)

CAPS Rating: 2 out of 5

A neuromodulation company founded to design, develop and bring to market medical devices that provide a unique therapy, VNS Therapy, for the treatment of epilepsy, TRD and other debilitating neurological or psychiatric diseases and other disorders.

Results 1 - 18 of 18

Recs

0
Member Avatar OklaBoston (68.19) Submitted: 5/11/2014 10:15:51 PM : Underperform Start Price: $60.12 CYBX Score: +2.76

NO WAY this should have climbed as high as it has.

I wouldn't pay more than $24 for it.

Recs

0
Member Avatar Marlonito9 (< 20) Submitted: 5/13/2012 4:33:00 AM : Underperform Start Price: $39.02 CYBX Score: -11.35

I think its best this way. I hope I 'll receive money by this.

Recs

0
Member Avatar veveyhedge (60.13) Submitted: 10/13/2011 12:27:32 AM : Outperform Start Price: $27.93 CYBX Score: +56.49

ITS IN THE RIGHT SPACE

Recs

0
Member Avatar VGQ (< 20) Submitted: 5/25/2010 4:32:18 PM : Outperform Start Price: $17.94 CYBX Score: +162.63

SC- MF/M

Recs

0
Member Avatar jammin200 (74.41) Submitted: 7/3/2009 11:47:07 AM : Outperform Start Price: $16.68 CYBX Score: +147.33

1/125 in Health Care Equipment -(73.7 @ B+/B+)

Recs

0
Member Avatar Cab53RobertMsnG (57.60) Submitted: 5/27/2009 12:28:18 PM : Outperform Start Price: $14.01 CYBX Score: +223.36

CYBX

Recs

0
Member Avatar randydeanw (23.96) Submitted: 10/4/2008 1:32:16 PM : Outperform Start Price: $16.01 CYBX Score: +197.17

Need some drugs

Recs

0
Member Avatar mjan706 (67.65) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $17.97 CYBX Score: +181.55

An Icahn portfolio stock.

Recs

0
Member Avatar SqwiiToN (< 20) Submitted: 9/1/2008 7:11:33 AM : Outperform Start Price: $21.84 CYBX Score: +126.42

RSI 5 - 30

Recs

0
Member Avatar ongkaili (50.73) Submitted: 7/9/2008 2:49:05 PM : Outperform Start Price: $24.70 CYBX Score: +87.75

no near competitors, good market (unfortunately) and a new management team seems ready to turn this company to be very profitable.

its gonna be unstoppable now.

Recs

0
Member Avatar vagusmania (< 20) Submitted: 6/23/2008 3:42:01 PM : Underperform Start Price: $23.54 CYBX Score: -107.64

You have to pay close attention to every slide on its most recent presentation.

Replacement sales increased by 75% in fiscal 2008 over 2007 and were the key driver of growth, masking the mediocre growth of sales of generators to new patients.

New patients sales are the key measurement of growth and penetration of the epilespy market. I would study, analyze and fully understand slide 11. De novo sales were flat year over year. The replacement sale cycle will drop in late fiscal 2009 and the company had better hope that there is a dramatic increase new patient sales.

Cyberonics's depression business is dead.

Recs

0
Member Avatar ryoung815 (42.93) Submitted: 6/11/2008 5:57:22 PM : Outperform Start Price: $19.25 CYBX Score: +169.36

They have expected high profitability for upcoming quarters, and have just reported increased financials. Still looking for some financing but I think an overall good pick.

Recs

0
Member Avatar fitz55 (54.17) Submitted: 6/9/2008 7:19:23 AM : Outperform Start Price: $18.01 CYBX Score: +194.08

rated high; growing

Recs

0
Member Avatar MrBuffetSentme (< 20) Submitted: 4/24/2008 7:09:15 PM : Outperform Start Price: $15.63 CYBX Score: +249.13

under valued this teck will be need more and more

Recs

7
Member Avatar OneStarHero (< 20) Submitted: 6/4/2007 8:39:42 PM : Outperform Start Price: $18.28 CYBX Score: +202.70

Finally, cyberspace and electronics have combined to cure epilepsy! I have a chronic disorder, and the only cure is big gains on CYBX!

Recs

2
Member Avatar NetscribeHealthC (28.59) Submitted: 3/12/2007 6:38:37 AM : Underperform Start Price: $18.48 CYBX Score: -185.46

Cyberonics is a neuromodulation company engaged in designing, developing and bringing to market medical devices that provide Vagus Nerve Stimulation (VNS) Therapy, for the treatment of epilepsy, treatment-resistant depression (TRD) and other debilitating neurological or psychiatric diseases, and other disorders.

VNS Therapy consists of the electrical stimulation of the Vagus nerve with an implantable device. The VNS Therapy System consists of a pulse generator, a bipolar lead, a programming wand and software and a tunneling tool. In July 2005, FDA also approved the VNS Therapy System for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode.

Net sales for the thirteen weeks ended January 2007 decreased by $1.0 million, or 4%, primarily as a result of 5% decrease in unit sales volumes partially offset by 2% rise in sales price. However, Cyberonics will remain a company that is struggling commercially which is seen from its slower than expected revenue growth in depression sales, substantial market development expenses and inadequate reimbursement. Its epilepsy business has low prospects for future growth, as new patient sales have remained flat.

Recently the Centers for Medicare and Medicaid Services (CMS) posted a proposed National Coverage Determination (NCD) arguing that there is sufficient evidence to conclude that Vagus nerve stimulation is not a reasonable treatment of resistant depression. This decision is bad news for Cyberonics, as this means that the company cannot expect help from CMS to pay for post-approval studies, and the cost will be left on the shoulders of Cyberonics. All these factors sum up to Cyberonics being a poor investment proposition.

Recs

0
Member Avatar geoffreyiles (< 20) Submitted: 12/9/2006 4:07:20 PM : Outperform Start Price: $25.85 CYBX Score: +90.79

Will be taken over.

Recs

0
Member Avatar regnig (96.92) Submitted: 11/22/2006 11:42:43 AM : Outperform Start Price: $25.85 CYBX Score: +90.25

this company will thrive either on its own or will be acquired

Results 1 - 18 of 18

Featured Broker Partners


Advertisement